What is the Entero Healthcare Solutions PE ratio today?
Entero Healthcare Solutions' PE ratio is 54.1 at the previous close (₹1,559.30 a share): a market capitalisation of ₹6,787 crore divided by consolidated net profit attributable to shareholders of ₹125 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹115 crore) it is 59.0.
What is the Entero Healthcare Solutions PB ratio (price to book value)?
Entero Healthcare Solutions' price-to-book (PB) ratio is 4.02 at the previous close: a market capitalisation of ₹6,787 crore divided by shareholders' equity (book value) of ₹1,689 crore on 31 March 2026. That is a book value of ₹387.98 per share against a share price of ₹1,559.30.
What is the Entero Healthcare Solutions net worth?
Entero Healthcare Solutions' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,689 crore on 31 March 2026, down 2.1% from ₹1,724 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹6,787 crore at the previous close.
What is the Entero Healthcare Solutions market cap?
Entero Healthcare Solutions' market capitalisation was ₹6,787 crore at the previous close: 4.35 crore shares at ₹1,559.30 each.
Is Entero Healthcare Solutions debt free?
No. Entero Healthcare Solutions had borrowings of ₹567 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.32. Its cash and current investments were ₹292 crore, so its net debt was ₹275 crore.
What is the Entero Healthcare Solutions EPS?
Entero Healthcare Solutions' basic earnings per share (EPS) were ₹26.44 in FY26, against ₹21.80 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹28.82.
What is the Entero Healthcare Solutions debt to equity ratio?
Entero Healthcare Solutions' debt-to-equity ratio was 0.32 on 31 March 2026: borrowings of ₹567 crore against total equity of ₹1,753 crore. A year earlier, on 31 March 2025, it was 0.17.
What is the Entero Healthcare Solutions revenue and profit in FY26?
In FY26 (April 2025–March 2026), Entero Healthcare Solutions' consolidated net profit attributable to shareholders was ₹115 crore, up 21.3% from ₹94.8 crore in FY25, on revenue from operations of ₹6,591 crore (up 29.3%).
When are the Entero Healthcare Solutions next results?
Entero Healthcare Solutions will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
What is the Entero Healthcare Solutions ROE and ROCE?
In FY26, Entero Healthcare Solutions' return on equity (ROE) was 6.7% and its return on capital employed (ROCE) was 11.5%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 5.6% and ROCE 7.8%.
What is the Entero Healthcare Solutions shareholding pattern?
On 30 September 2026, Entero Healthcare Solutions' shares were held by promoters 52.40%, foreign portfolio investors (FII/FPI) 5.77%, domestic institutions (DII) 21.16% (including mutual funds at 11.15%) and retail and other non-institutional investors 20.67%. Over the year, FII holding was down 8.90 percentage points from 14.67% and DII holding was up 11.51 percentage points from 9.65%.
How does Entero Healthcare Solutions compare with its peers?
On FY26 consolidated figures, against Medplus Health Services, Electronics Mart India and Crizac: Entero Healthcare Solutions' operating margin of 3.4% is the lowest of the four (Medplus Health Services 4.7%, Electronics Mart India 3.9%, Crizac 24.8%; peer average 11.1%); its return on equity of 6.7% is the lowest of the four (Medplus Health Services 11.8%, Electronics Mart India 6.8%, Crizac 37.5%; peer average 18.7%).
What is the Entero Healthcare Solutions book value per share?
Entero Healthcare Solutions' book value per share was ₹387.98 on 31 March 2026: shareholders' equity of ₹1,689 crore divided by the 4.35 crore shares in issue, down 2.1% from ₹396.28 a year earlier. The share price at the previous close was ₹1,559.30.
What is the Entero Healthcare Solutions promoter holding?
Promoters held 52.40% of Entero Healthcare Solutions on 30 September 2026, unchanged from the previous quarter and down 0.02 percentage points from 52.42% a year earlier, according to the shareholding pattern filed with NSE.
What is the Entero Healthcare Solutions free cash flow?
In FY26, Entero Healthcare Solutions generated ₹96.2 crore of cash from operations and spent ₹67.5 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹28.7 crore. In FY25 it was −₹88.2 crore.
What are the Entero Healthcare Solutions latest quarterly results?
Entero Healthcare Solutions' latest results are for Q1 FY27 (April–June 2026), filed on 7 August 2026: consolidated net profit attributable to shareholders ₹38.2 crore, up 37.3% from ₹27.8 crore in Q1 FY26; revenue from operations ₹1,940 crore, up 38.2% year on year.
Entero Healthcare Solutions vs Medplus Health Services: how do they compare?
In FY26, Entero Healthcare Solutions earned net profit attributable to shareholders of ₹115 crore on revenue of ₹6,591 crore, against ₹220 crore on ₹6,892 crore for Medplus Health Services. Entero Healthcare Solutions' operating margin was 3.4% (Medplus Health Services 4.7%) and its return on equity 6.7% (Medplus Health Services 11.8%).
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
